SCHEMBL24510741

SCHEMBL24510741

COc1ccn2c(C(C)=O)cc(Br)c2c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BAZ2B Q9UIF8 8/20 0.57
▸ BAZ2A Q9UIF9 7/20 0.57
▸ BRD9 Q9H8M2 4/20 0.52
▸ SMARCA2 P51531 1/20 0.52
▸ SMARCA4 P51532 1/20 0.52
▸ TP53 P04637 1/20 0.44
▸ FNTA P49354 2/20 0.42
▸ FNTB P49356 2/20 0.42
▸ CREBBP Q92793 5/20 0.41
▸ TRIM33 Q9UPN9 2/20 0.40
▸ TRIM24 O15164 1/20 0.40
▸ TAF1L Q8IZX4 1/20 0.40
▸ MTNR1A P48039 1/20 0.39
▸ MTNR1B P49286 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510740 0.81 FNTA (0.60) BAZ2BBAZ2ABRD9SMARCA2SMARCA4
SCHEMBL25400578 0.80 BAZ2B (0.45) BAZ2BBAZ2ABRD9TP53ALDH1A1
SCHEMBL24510742 0.79 BAZ2B (0.55) BAZ2BBAZ2ABRD9SMARCA2SMARCA4
SCHEMBL25402588 0.77 LMNA (0.46) TP53FNTAFNTBALDH1A1HPGD
SCHEMBL18556097 0.75 FNTA (0.54) BAZ2BBAZ2ABRD9SMARCA2SMARCA4
SCHEMBL25399546 0.75 BAZ2B (0.38) BAZ2BBAZ2ABRD9ALDH1A1HPGD
SCHEMBL25401668 0.74 BAZ2B (0.62) BAZ2BBAZ2ABRD9TP53FNTA
SCHEMBL24510745 0.72 BAZ2B (1.00) BAZ2BBAZ2ABRD9SMARCA2SMARCA4
SCHEMBL23318447 0.72 BAZ2B (0.65) BAZ2BBAZ2ABRD9SMARCA2SMARCA4
SCHEMBL18555942 0.70 BAZ2B (0.47) BAZ2BBAZ2ABRD9SMARCA2SMARCA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4259133-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2023-10-18 — — EP disclosed
WO-2022126000-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2022-06-16 — — WO disclosed
WO-2022126000-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2022-06-16 — — WO disclosed
Send feedback